Portfolio / Bioceros

Bioceros.gif


Bioceros offers cell line generation services related to the preclinical development of monoclonal antibodies and generation of GMP-ready protein producing cell lines. They have a toolbox to modify product characteristics according to customer needs, and (bio-)analytics including mass spectrometry.

Together with the other divisions of the Polpharma Group, which has acquired Bioceros, they offer a completely integrated program from DNA to the drug product.

Website

Company: bioceros

Fund: I

Status: Realized

Team member:

Michel Briejer

05.jpg
 

Technology:

Therapeutics

Icons-Creteria_Medical-technologymedical-devices.png